ORIGINAL ARTICLE


Open Access Peer-Reviewed

2714

Views

Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies

Vol.41 Issue 6/2019:


Message

 


© 2026 All rights reserved